Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Department of Biotechnology, Institute of Science, Visva Bharati University, Bolpur, West Bengal, India.
J Infect Dis. 2022 Nov 11;226(10):1842-1851. doi: 10.1093/infdis/jiac354.
Incidence of visceral leishmaniasis (VL) in the Indian subcontinent (ISC) has declined by more than 95% since initiation of the elimination program in 2005. As the ISC transitions to the postelimination surveillance phase, an accurate measurement of human-vector contact is needed to assure long-term success. To develop this tool, we identified PagSP02 and PagSP06 from saliva of Phlebotomus argentipes, the vector of Leishmania donovani in the ISC, as immunodominant proteins in humans. We also established the absence of cross-reactivity with Phlebotomus papatasi saliva, the only other human-biting sand fly in the ISC. Importantly, by combining recombinant rPagSP02 and rPagSP06 we achieved greater antibody recognition and specificity than single salivary proteins. The receiver operating characteristics curve for rPagSP02 + rPagSP06 predicts exposure to Ph. argentipes bites with 90% specificity and 87% sensitivity compared to negative control sera (P >.0001). Overall, rPagSP02 + rPagSP06 provides an effective surveillance tool for monitoring vector control efforts after VL elimination.
印度次大陆(ISC)内脏利什曼病(VL)的发病率自 2005 年启动消除规划以来下降了 95%以上。随着 ISC 过渡到消除后监测阶段,需要准确测量人与媒介的接触情况,以确保长期成功。为了开发这一工具,我们从印度次大陆利什曼原虫的媒介白蛉属的唾液中鉴定出 PagSP02 和 PagSP06,它们是人类的免疫显性蛋白。我们还证实了它们与 ISC 中唯一另一种叮咬人类的沙蝇白蛉属的唾液没有交叉反应。重要的是,通过组合重组 rPagSP02 和 rPagSP06,我们实现了比单个唾液蛋白更高的抗体识别和特异性。与阴性对照血清相比,rPagSP02 + rPagSP06 的受试者工作特征曲线(ROC)对接触白蛉属叮咬的预测具有 90%的特异性和 87%的敏感性(P >.0001)。总体而言,rPagSP02 + rPagSP06 为监测 VL 消除后控制媒介的努力提供了一种有效的监测工具。